Published in J Pathol on February 01, 2014
Macrophages in Tissue Repair, Regeneration, and Fibrosis. Immunity (2016) 1.22
Monocytes are recruited from venules during arteriogenesis in the murine spinotrapezius ligation model. Arterioscler Thromb Vasc Biol (2014) 0.82
Therapeutic strategies for preventing skeletal muscle fibrosis after injury. Front Pharmacol (2015) 0.80
Phagocyte-myocyte interactions and consequences during hypoxic wound healing. Cell Immunol (2014) 0.80
Effects of hyperbaric oxygen at 1.25 atmospheres absolute with normal air on macrophage number and infiltration during rat skeletal muscle regeneration. PLoS One (2014) 0.79
Anti-inflammatory macrophages improve skeletal muscle recovery from ischemia-reperfusion. J Appl Physiol (1985) (2015) 0.78
The Development of Macrophage-Mediated Cell Therapy to Improve Skeletal Muscle Function after Injury. PLoS One (2015) 0.78
Asynchronous inflammation and myogenic cell migration limit muscle tissue regeneration mediated by a cellular scaffolds. Inflamm Cell Signal (2015) 0.77
Severe muscle trauma triggers heightened and prolonged local musculoskeletal inflammation and impairs adjacent tibia fracture healing. J Musculoskelet Neuronal Interact (2016) 0.77
Macrophages are necessary for epimorphic regeneration in African spiny mice. Elife (2017) 0.75
MicroRNA-155 facilitates skeletal muscle regeneration by balancing pro- and anti-inflammatory macrophages. Cell Death Dis (2016) 0.75
Defining the Balance between Regeneration and Pathological Ossification in Skeletal Muscle Following Traumatic Injury. Front Physiol (2017) 0.75
Therapeutic potential of adipose-derived stem cells and macrophages for ischemic skeletal muscle repair. Regen Med (2017) 0.75
What Can be Learned from the Time Course of Changes in Low-Frequency Stimulated Muscle? Eur J Transl Myol (2017) 0.75
Timed Delivery of Therapy Enhances Functional Muscle Regeneration. Adv Healthc Mater (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 19.38
Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 12.21
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest (2005) 8.58
Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med (1992) 8.46
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med (2007) 7.87
Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol (2005) 5.20
Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol (2011) 4.76
Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol (1993) 3.14
The phenotype of murine wound macrophages. J Leukoc Biol (2010) 3.13
Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int (2007) 3.09
A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med (2006) 2.28
Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet (2008) 2.27
Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology (2011) 2.27
Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol (2003) 2.19
Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol (2000) 2.18
Host responses in tissue repair and fibrosis. Annu Rev Pathol (2012) 2.10
Macrophages in skin injury and repair. Immunobiology (2011) 2.00
Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am J Physiol Endocrinol Metab (2010) 1.94
Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. Am J Physiol Regul Integr Comp Physiol (2006) 1.94
Wound macrophages as key regulators of repair: origin, phenotype, and function. Am J Pathol (2010) 1.83
Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart. Circulation (2006) 1.77
Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect Immun (2006) 1.76
Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. Genes Dev (2008) 1.73
Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum Mol Genet (2010) 1.59
Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res (2000) 1.57
Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling. Circulation (2012) 1.54
The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med (2001) 1.46
Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol (1996) 1.45
Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice. Cytokine (2011) 1.42
Suturing versus immobilization of a muscle laceration. A morphological and functional study in a mouse model. Am J Sports Med (1999) 1.19
Urokinase-type plasminogen activator plays essential roles in macrophage chemotaxis and skeletal muscle regeneration. J Immunol (2008) 1.17
Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy. PLoS One (2010) 1.16
NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis. Am J Pathol (2005) 1.16
Tissue microenvironments define and get reinforced by macrophage phenotypes in homeostasis or during inflammation, repair and fibrosis. J Innate Immun (2012) 1.13
Macrophage-secreted myogenic factors: a promising tool for greatly enhancing the proliferative capacity of myoblasts in vitro and in vivo. Neurol Sci (2002) 1.12
Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration. Am J Physiol Cell Physiol (2005) 1.07
Regulation of chemokine expression by antiinflammatory cytokines. Immunol Res (2002) 1.07
Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages. Am J Physiol (1999) 1.06
IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radic Biol Med (2012) 1.06
Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation. Mol Ther (2012) 1.01
Regeneration versus fibrosis in skeletal muscle. Curr Opin Rheumatol (2011) 0.98
Treatment of human ulcers by application of macrophages prepared from a blood unit. Exp Gerontol (1998) 0.98
Treatment of deep sternal wound infections post-open heart surgery by application of activated macrophage suspension. Wound Repair Regen (2005) 0.92
Diabetes-impaired wound healing and altered macrophage activation: a possible pathophysiologic correlation. Wound Repair Regen (2012) 0.89
Macrophage suspensions prepared from a blood unit for treatment of refractory human ulcers. Transfus Apher Sci (2004) 0.87
The urokinase-type plasminogen activator receptor is not required for skeletal muscle inflammation or regeneration. Am J Physiol Regul Integr Comp Physiol (2007) 0.84
Urokinase-type plasminogen activator contributes to heterogeneity of macrophages at the border of damaged site during liver repair in mice. Thromb Haemost (2011) 0.82
Hard to heal pressure ulcers (stage III-IV): efficacy of injected activated macrophage suspension (AMS) as compared with standard of care (SOC) treatment controlled trial. Arch Gerontol Geriatr (2010) 0.82
Evidence-based treatment of hamstring tears. Curr Sports Med Rep (2009) 0.81
Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol (2009) 2.45
Macrophage phenotypes during tissue repair. J Leukoc Biol (2013) 1.67
Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice. Cytokine (2011) 1.42
Advanced Technologies to Improve Wound Healing: Electrical Stimulation, Vibration Therapy, and Ultrasound-What Is the Evidence? Plast Reconstr Surg (2016) 1.38
Phenotypic transitions of macrophages orchestrate tissue repair. Am J Pathol (2013) 1.36
Neutrophils contribute to muscle injury and impair its resolution after lengthening contractions in mice. J Physiol (2004) 1.28
Blocking interleukin-1β induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetes. Diabetes (2013) 1.22
Urokinase-type plasminogen activator plays essential roles in macrophage chemotaxis and skeletal muscle regeneration. J Immunol (2008) 1.17
Endogenous interferon-gamma is required for efficient skeletal muscle regeneration. Am J Physiol Cell Physiol (2008) 1.15
Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice. Diabetes (2013) 1.14
Intracellular signaling specificity in response to uniaxial vs. multiaxial stretch: implications for mechanotransduction. Am J Physiol Cell Physiol (2004) 1.14
Urokinase-type plasminogen activator and macrophages are required for skeletal muscle hypertrophy in mice. Am J Physiol Cell Physiol (2007) 1.12
Functional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoprotein. Carcinogenesis (2010) 1.11
Muscle inflammatory cells after passive stretches, isometric contractions, and lengthening contractions. J Appl Physiol (1985) (2002) 1.06
COX-2 inhibitor reduces skeletal muscle hypertrophy in mice. Am J Physiol Regul Integr Comp Physiol (2009) 1.05
HSP25 protects skeletal muscle cells against oxidative stress. Free Radic Biol Med (2004) 1.03
Impaired muscle regeneration in ob/ob and db/db mice. ScientificWorldJournal (2011) 1.02
Improved transfection technique for adherent cells using a commercial lipid reagent. Biotechniques (2003) 0.98
Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration. Blood (2009) 0.93
The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice. Blood (2011) 0.90
Macrophage-specific expression of urokinase-type plasminogen activator promotes skeletal muscle regeneration. J Immunol (2011) 0.89
The urokinase-type plasminogen activator receptor is not required for skeletal muscle inflammation or regeneration. Am J Physiol Regul Integr Comp Physiol (2007) 0.84
Mechanical strain increases gene transfer to skeletal muscle cells. J Biomech (2006) 0.81
Three-Dimensional in Vivo Kinematics of the Shoulder during Humeral Elevation. J Appl Biomech (1998) 0.75